BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo Y, Lucas AL, Grinspan AM. Fecal Transplants by Colonoscopy and Capsules Are Cost-Effective Strategies for Treating Recurrent Clostridioides difficile Infection. Dig Dis Sci 2020;65:1125-33. [DOI: 10.1007/s10620-019-05821-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Dhere T, Tager D, Kilakkathi SP, Woodworth MH, Kraft CS. Earlier use of fecal transplant administration during hospitalization for Clostridioides difficile infectionmay improve outcome. Eur J Gastroenterol Hepatol 2021;33:1132-3. [PMID: 34213510 DOI: 10.1097/MEG.0000000000002159] [Reference Citation Analysis]
2 Fu Y, Luo Y, Grinspan AM. Epidemiology of community-acquired and recurrent Clostridioides difficile infection. Therap Adv Gastroenterol 2021;14:17562848211016248. [PMID: 34093740 DOI: 10.1177/17562848211016248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Malloy E, Kates A, Watson L, VandeVusse L, Safdar N, Hanson L. Laboratory Analysis Techniques for the Perinatal Microbiome: Implications for Studies of Probiotic Interventions. J Perinat Neonatal Nurs 2020;34:239-50. [PMID: 32697544 DOI: 10.1097/JPN.0000000000000496] [Reference Citation Analysis]
4 Hammeken LH, Baunwall SMD, Hvas CL, Ehlers LH. Health economic evaluations comparing faecal microbiota transplantation with antibiotics for treatment of recurrent Clostridioides difficile infection: a systematic review. Health Econ Rev 2021;11:3. [PMID: 33439367 DOI: 10.1186/s13561-021-00301-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kumar V, Fischer M. Expert opinion on fecal microbiota transplantation for the treatment of Clostridioides difficile infection and beyond. Expert Opin Biol Ther. 2020;20:73-81. [PMID: 31690143 DOI: 10.1080/14712598.2020.1689952] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
6 Du C, Luo Y, Walsh S, Grinspan A. Oral Fecal Microbiota Transplant Capsules Are Safe and Effective for Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis. J Clin Gastroenterol 2021;55:300-8. [PMID: 33471490 DOI: 10.1097/MCG.0000000000001495] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 You JHS, Jiang X, Lee WH, Chan PKS, Ng SC. Cost‐effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with inflammatory bowel disease. Journal of Gastroenterology and Hepatology 2020;35:1515-23. [DOI: 10.1111/jgh.15002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
8 Kaźmierczak-Siedlecka K, Skonieczna-Żydecka K, Biliński J, Roviello G, Iannone LF, Atzeni A, Sobocki BK, Połom K. Gut Microbiome Modulation and Faecal Microbiota Transplantation Following Allogenic Hematopoietic Stem Cell Transplantation. Cancers (Basel) 2021;13:4665. [PMID: 34572894 DOI: 10.3390/cancers13184665] [Reference Citation Analysis]